Clinical Trial Update: A Study of Nipocalimab in Participants With Active Idiopathic Inflammatory Myopathies [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update for Nipocalimab in participants with active idiopathic inflammatory myopathies (myositis), noting the study is currently active …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Inflammatory Myopathies
• Myositis

Drugs mentioned

• Nipocalimab (nipocalimab)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Myositis | Phase 2 | Status: ACTIVE_NOT_RECRUITING